The Medicines Control Authority of Zimbabwe (MCAZ) is targeting to broaden its regulatory scope and venture into medical products that include diagnostics and blood products.
The authority celebrated its 20th anniversary at the weekend.
Since its birth in 1997, the MCAZ has played a pivotal role as an effective medicines regulator which has positively impacted in the maintenance of standards within the country’s health delivery sector.
The process to expand the authority’s regulatory scope started in 2015 through the gazetting of the complementary medicines regulations.
“These are currently being enforced to ensure compliance of manufacturers and distributors with the broader vision looking at incorporating diagnostics, said MCAZ director general Ms Gugu Mahlangu.
The hallmark of this success has largely been anchored on sound corporate governance by the authority according to Health and Child Care Minister, Dr David Parirenyatwa.
The MCAZ has made notable strides over the last five years since 2012 resulting in it expanding its testing services regulatory training to several countries within the continent and beyond including Burkina Faso, Syria, Uzbekistan and Tajikistan.